Man Group
BBIO icon

Man Group’s BridgeBio Pharma BBIO Stock Holding History

Man Group’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Sell
27,526
-681
-2% -$47.7K ﹤0.01% 1560
2026
Q1 		$2.09M Buy
28,207
+8,203
+41% +$595K ﹤0.01% 1556
2025
Q4 		$1.53M Buy
20,004
+5,487
+38% +$360K ﹤0.01% 1550
2025
Q3 		$754K Sell
14,517
-120,908
-89% -$5.9M ﹤0.01% 1757
2025
Q2 		$5.85M Buy
135,425
+117,277
+646% +$4.27M 0.01% 995
2025
Q1 		$627K Buy
+18,148
New +$612K ﹤0.01% 1718
2024
Q3 		– Sell
-619,927
Closed -$15.7M – 1969
2024
Q2 		$15.7M Buy
+619,927
New +$16.9M 0.04% 509
2024
Q1 		– Sell
-7,100
Closed -$287K – 2117
2023
Q4 		$287K Buy
+7,100
New +$213K ﹤0.01% 1827
2023
Q1 		– Sell
-28,673
Closed -$218K – 2077
2022
Q4 		$218K Sell
28,673
-14,416
-33% -$138K ﹤0.01% 1739
2022
Q3 		$429K Buy
+43,089
New +$448K ﹤0.01% 1559
2022
Q2 		– Sell
-65,107
Closed -$545K – 1845
2022
Q1 		$661K Buy
+65,107
New +$668K ﹤0.01% 1500
2021
Q3 		– Sell
-4,552
Closed -$278K – 1900
2021
Q2 		$278K Sell
4,552
-55,146
-92% -$3.15M ﹤0.01% 1700
2021
Q1 		$3.68M Sell
59,698
-78,287
-57% -$5.12M 0.02% 841
2020
Q4 		$9.81M Buy
137,985
+13,963
+11% +$674K 0.04% 457
2020
Q3 		$4.65M Buy
124,022
+6,237
+5% +$196K 0.02% 849
2020
Q2 		$3.84M Buy
+117,785
New +$3.59M 0.02% 797

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Man Group's BBIO Position: Q2 2026 in Review

Man Group reduced its BridgeBio Pharma (BBIO) stake by 2.4% in Q2 2026, selling an estimated $47.7K and leaving 27,526 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

Man Group first reported a position in BBIO in Q2 2020 and has held it in 16 quarters since. The position peaked at $15.7M in Q2 2024. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Man Group held 27,526 shares of BridgeBio Pharma worth $2.05M as of Q2 2026.
  • Man Group sold 681 BridgeBio Pharma shares in Q2 2026, an estimated $47.7K.
  • BridgeBio Pharma made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1560 holding.
  • Man Group first reported a position in BridgeBio Pharma in Q2 2020 and has held it in 16 quarters since.
  • Man Group's BridgeBio Pharma position peaked at $15.7M in Q2 2024.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.